Please login to the form below

Not currently logged in
Email:
Password:

Corporate Responsibility Award

Finalist

EXcellence in Ophthalmology Vision Award (XOVA) 2010

Novartis Pharma AG in association with Alpha-Plus Medical Communications (Fishawack Group)


Summary of work

In 2010, Novartis combined its leadership in ophthalmology and established Corporate Citizenship policy to develop the EXcellence in Ophthalmology Vision Award (XOVA) programme. The programme, aimed to provide at least two grants for non-profit educational or innovative initiatives, was designed to have a clear and positive impact on improving the quality of ophthalmic care.

With 121 submissions from 37 countries, the number of entries significantly outstripped the target of 50. Three winners, chosen by an expert faculty, were recognised at the CME-accredited Age-related Macular Degeneration congress in Switzerland in October 2010. The winning projects came from Timor Leste, East Africa and India.

Judges comments

“This programme allowed people to do different things. The solution fitted the specific issue and is not homogenised in any way. It’s a truly sustainable programme.”

Stakeholder comments

“It is with great honour and excitement that we acknowledge your decision to select the East Timor Eye Program (ETEP) for the Novartis EXcellence in Ophthalmology Vision Award for Innovation.”
Doctor, Royal Australasian College of Surgeons, Australia

“We are very pleased with the response to the XOVA programme in its first year, and excited at the ideas and energy we have seen. We have had excellent feedback from our country colleagues and from the judging faculty. XOVA will remain a core part of the Neuroscience and Ophthalmology franchise’s commitment to Corporate Citizenship and we are very much looking forward to seeing the entries in 2011.”
Global Brand Manager, Ophthalmics, Novartis Pharma AG